These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7543443)

  • 21. The utility of basal cell-specific anti-cytokeratin antibody (34 beta E12) in the diagnosis of prostate cancer. A review of 228 cases.
    Wojno KJ; Epstein JI
    Am J Surg Pathol; 1995 Mar; 19(3):251-60. PubMed ID: 7532918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atypical adenomatous hyperplasia of the prostate: a premalignant lesion?
    Cheng L; Shan A; Cheville JC; Qian J; Bostwick DG
    Cancer Res; 1998 Feb; 58(3):389-91. PubMed ID: 9458077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinguishing Cowper's glands from neoplastic and pseudoneoplastic lesions of prostate: immunohistochemical and ultrastructural studies.
    Saboorian MH; Huffman H; Ashfaq R; Ayala AG; Ro JY
    Am J Surg Pathol; 1997 Sep; 21(9):1069-74. PubMed ID: 9298883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Premalignant lesions of prostate and their association with nodular hyperplasia and carcinoma prostate.
    Rekhi B; Jaswal TS; Arora B
    Indian J Cancer; 2004; 41(2):60-5. PubMed ID: 15318010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atypical adenomatous hyperplasia (adenosis) of the prostate: development of a Bayesian belief network for its distinction from well-differentiated adenocarcinoma.
    Montironi R; Bartels PH; Hamilton PW; Thompson D
    Hum Pathol; 1996 Apr; 27(4):396-407. PubMed ID: 8617484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mucins in prostatic intra-epithelial neoplasia and prostatic carcinoma.
    Sentinelli S
    Histopathology; 1993 Mar; 22(3):271-4. PubMed ID: 7684356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pseudohyperplastic prostatic adenocarcinoma in transurethral resections of the prostate.
    Arista-Nasr J; Martinez-Benitez B; Valdes S; Hernández M; Bornstein-Quevedo L
    Pathol Oncol Res; 2003; 9(4):232-5. PubMed ID: 14688829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of keratin 903 as an adjunct in the diagnosis of prostate carcinoma.
    Hedrick L; Epstein JI
    Am J Surg Pathol; 1989 May; 13(5):389-96. PubMed ID: 2469333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell kinetic studies on prostatic intraepithelial neoplasia (PIN) and atypical adenomatous hyperplasia (AAH) of the prostate.
    Helpap B
    Pathol Res Pract; 1995 Sep; 191(9):904-7. PubMed ID: 8606872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in the structural features of atypical adenomatous hyperplasia and low-grade prostatic adenocarcinoma.
    Midi A; Tecimer T; Bozkurt S; Ozkan N
    Indian J Urol; 2008 Apr; 24(2):169-77. PubMed ID: 19468392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Localization of epidermal growth factor receptor by immunohistochemical methods in human prostatic carcinoma, prostatic intraepithelial neoplasia, and benign hyperplasia.
    Maygarden SJ; Strom S; Ware JL
    Arch Pathol Lab Med; 1992 Mar; 116(3):269-73. PubMed ID: 1371380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A theoretical rationale on the histogenesis of premalignant lesions and early carcinoma of the prostate.
    Botticelli AR
    Pathologica; 1994 Apr; 86(2):128-41. PubMed ID: 7524011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective origins of prostate carcinoma. Prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia.
    Bostwick DG
    Cancer; 1996 Jul; 78(2):330-6. PubMed ID: 8674012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p63 protein expression is rare in prostate adenocarcinoma: implications for cancer diagnosis and carcinogenesis.
    Parsons JK; Gage WR; Nelson WG; De Marzo AM
    Urology; 2001 Oct; 58(4):619-24. PubMed ID: 11597556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostatic intraepithelial neoplasia in surgical resections: relationship to coexistent adenocarcinoma and atypical adenomatous hyperplasia of the prostate.
    Skjørten FJ; Berner A; Harvei S; Robsahm TE; Tretli S
    Cancer; 1997 Mar; 79(6):1172-9. PubMed ID: 9070495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System.
    Pierconti F; Martini M; Cenci T; Petrone GL; Ricci R; Sacco E; Bassi PF; Larocca LM
    Prostate; 2017 May; 77(6):597-603. PubMed ID: 28144985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microcystic adenocarcinoma of the prostate: a variant of pseudohyperplastic and atrophic patterns.
    Yaskiv O; Cao D; Humphrey PA
    Am J Surg Pathol; 2010 Apr; 34(4):556-61. PubMed ID: 20216381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Verumontanum mucosal gland hyperplasia is associated with atypical adenomatous hyperplasia of the prostate.
    Muezzinoglu B; Erdamar S; Chakraborty S; Wheeler TM
    Arch Pathol Lab Med; 2001 Mar; 125(3):358-60. PubMed ID: 11231483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Benign microglandular prostate lesions. Diagnostic criteria na differential diagnosis].
    Bonkhoff H; Remberger K
    Pathologe; 1998 Jan; 19(1):1-11. PubMed ID: 9541937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mucin in prostatic adenocarcinoma.
    Ro JY; Grignon DJ; Troncoso P; Ayala AG
    Semin Diagn Pathol; 1988 Aug; 5(3):273-83. PubMed ID: 2459752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.